EN DE

Bath & Body Works Inc. (BBWI) Fair Value & Analysis

Consumer Cyclical · US · Market cap $4.1B · ISIN US0708301041

What is Bath & Body Works Inc. really worth?

BB Bath & Body Works Inc. logo Bath & Body Works Inc. BBWI · US
Price$18.97
Fair Value$40.82
Upside+115.2%
Quality70/100

A solid business, trading 54% below our fair value of $40.82.

Watch Bath & Body Works Inc. for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card. Watch for free

Strengths

Solidly profitable · 10.0% net margin
Negative equity (buybacks among others) · generates free cash flow
Ranks above peers (10/14)

Risks

!Mixed Growth (revenue 5y +2.5 %/yr)
!Moderate moat 54/100
!Evidence only medium, so the estimate is less certain

For context

·4.22% dividend yield
Evidence: Medium Range $26.50 – $55.23

Fair value as of: Aug 27, 2026

From 21 valuation models · updated 8 days ago

Share price −9.9% over the past month.

What runs behind every stock

69 individual criteria per stock, every one traceable See the method →

What matters now

  • The rarer combination: high quality (70/100) AND below fair value. That earns a closer look rather than a quick verdict.
  • The price is below even our cautious bear case ($26.50). The market is more pessimistic than our downside scenario.
  • A fairly wide model range ($26.50 to $55.23) leaves room in how you read the outcome.

Price vs Fair Value (5 years)

$69.89 $14.56 Fair Value $40.82 Jun 2021 Sep 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Aug 27, 2026.

How to read this chart

60‑month range $14.56 – $69.89 · fair‑value band $26.50 – $55.23 · the $18.97 price screens below the $40.82 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Aug 27, 2026.

Full chart & analysis →

Which stocks are undervalued right now? Check free Discover now →

Analysis

Bath & Body Works Inc. (BBWI) currently trades at $18.97, while our model-based Fair Value estimate is $40.82, implying the stock looks roughly 53.5% undervalued today. The Quality Score stands at 70/100 (solid quality), in the Consumer Cyclical sector. Bull case: the Multiples group reads highest at a median of $68.97 per share, and 19 of the 21 models we run sit above the $18.97 price. Bear case: the Dividend Discount group reads lowest at $8.65, and 2 of the 21 models stay below the price. Evidence for this calculation is medium.

Over the trailing twelve months, Bath & Body Works Inc. generated revenue of $7.2B at a net margin of 10.0%. Revenue declined 3.2% year over year. Net debt stands at $4.0B. The stock trades on a trailing P/E of 5.4. Fundamentals as of Aug 27, 2026

Our scenario range runs from $26.50 (bear case) to $55.23 (bull case); at $18.97, the current price sits below that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 42% below its 52-week high and 35% above its 52-week low, currently below its 200-day average. For context, the median of 10 Consumer Cyclical peers we cover trades at −11% fair-value upside, at 115%, BBWI screens cheaper than that median.

Fair Value models

This estimate rests on fiscal year 2026 figures, and about 7 months have passed since. In that time the company retained roughly $1.62 per share, which is 4.0 % of the fair value. The fair value deliberately does not add this in: the models value reported figures, not a projection.

Each model estimates fair value its own way; the Fair Value above is the evidence-weighted, family-balanced blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small. Every input is real reported data, nothing guessed.

Model Bear Bear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull Bull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. Evidence
Highest evidence
FCF DCF $27.76 $41.09 $67.18 79
Growth DCF $29.27 $42.24 $65.44 78
Owner Earnings $18.34 $28.60 $48.69 74
All 21 models by family
DCF Models
FCF DCF $27.76 $41.09 $67.18 79
Owner Earnings $18.34 $28.60 $48.69 74
5Y Revenue Exit $19.92 $32.74 $52.07 71
5Y EBITDA Exit $35.16 $58.61 $90.73 74
5Y P/E Exit $30.70 $51.05 $76.21 70
10Y Revenue Exit $21.94 $33.22 $45.74 67
10Y EBITDA Exit $31.86 $49.80 $69.94 68
10Y P/E Exit $29.19 $44.95 $60.85 64
Earnings-Based
Graham-Dodd $21.90 $34.95 $42.08 67
EPV $27.08 $33.44 $38.93 74
Dividend Discount
Gordon GGM $7.28 $8.65 $10.14 69
DDM Multi-Stage $7.28 $9.50 $12.20 67
Multiples
P/E Multiple $53.13 $70.84 $88.55 63
P/S Multiple $32.56 $43.41 $54.26 58
EV/EBIT $62.22 $87.36 $112.50 65
EV/EBITDA $48.43 $68.97 $89.51 67
EV/Revenue $17.19 $30.22 $43.24 52
Growth DCF
Growth DCF $29.27 $42.24 $65.44 78
Rev-Margin DCF $19.92 $33.70 $51.39 71
Economic Profit
ROIC Compounder $27.39 $34.28 $40.91 72
Growth Earnings
Growth-Adj P/E $37.45 $53.50 $69.55 67

Widest divergence: Multiples ($68.97) versus Dividend Discount ($8.65). Highest evidence: FCF DCF (79).

Notify me when BBWI reaches fair value

Put BBWI on your watchlist. We get in touch as soon as price and fair value meet or the trend turns.

Set up alert →

Free, no payment details. Unsubscribe anytime in one click.

Key figures & financial health

P/E ratio 5.4
P/S ratio 0.48 P/E × margin
EPS (TTM) $3.52 price ÷ EPS = P/E 5.4
Dividend yield 4.2% payout 22.7%
Net margin 8.9% FY2026
Return on assets (EBIT) 26.0% avg 5y
More key figures
Profitability
Operating margin 11.0% TTM
Growth
Revenue (TTM) $7.2B TTM
Revenue growth (YoY) −3.2% 3y avg −1.2%
EPS growth (YoY) +83.7%
Balance sheet & cash flow
Free cash flow $865M FY2026
Net debt $4.0B FY2026 · ≈ 4.6 yrs of FCF

Figures from reported company fundamentals · as of Aug 27, 2026. TTM = trailing twelve months.

Quality Score breakdown

Overall quality 70/100

Of which business quality 68 · Market factors (momentum, volatility) 21

Profitability 80
Margins and returns on capital today
Quality Growth 23
Are margins and returns improving?
Cashflow 67
Earnings quality: real cash, not paper profit
Fin. Strength 49
Balance sheet, leverage, solvency risk
Investment 97
Disciplined investing over empire-building
Low Volatility 17
Calm price path (market factor)
Momentum 27
Price trend over the last 3–12 months (market factor)
52W Momentum 14
Distance to the 52-week high (market factor)
Net Issuance 100
Buybacks instead of dilution

Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.

All values are scores from 0 to 100 (100 = best against fixed, research-based bands), not percentages. The three market factors (momentum, 52-week proximity, low volatility) are displayed but carry zero weight in the headline number: market sentiment is not a business property.

About the company

Bath & Body Works, Inc. operates as a specialty retailer of personal care and home fragrance products. The company offers body and home fragrances, including 3-wick candles, home fragrance diffusers, fine fragrance mists, eau de parfum, body wash, hand soaps, body lotions, and body creams, as well as sanitizer and other products.

Full company description

Bath & Body Works, Inc. operates as a specialty retailer of personal care and home fragrance products. The company offers body and home fragrances, including 3-wick candles, home fragrance diffusers, fine fragrance mists, eau de parfum, body wash, hand soaps, body lotions, and body creams, as well as sanitizer and other products. It sells its products under the Bath & Body Works and other brand names through retail stores and e-commerce sites in the United States and Canada, as well as through international stores operated by partners under the franchise, license, and wholesale arrangements. The company was formerly known as L Brands, Inc. and changed its name to Bath & Body Works, Inc. in August 2021. Bath & Body Works, Inc. was founded in 1963 and is headquartered in Columbus, Ohio.

Company description, as reported by the company or data provider.

Revenue & earnings trend

FY2022 – FY2026 · reported fiscal years

Bath & Body Works Inc. reported revenue of $7.3B in FY2026 versus $7.9B in FY2022, a compound −1.9%/yr. Reported net income was $649M in FY2026, compounding −16.5%/yr from FY2022.

Growth Quality 62/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Latest Revenue (FY 2026)
$7.3B
Latest YoY
−0.2%
Avg. revenue growth/yr (3Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
−1.2%
Avg. revenue growth/yr (5Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+2.5%
Avg. revenue growth/yr (40Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+2.8%
Value creation/yr (5Y) Earnings growth per share (CAGR 5 years, adjusted) plus dividend yield: value created per share and year.
+4.6% (0.4 + 4.2)
Revenue −1.9%/yr
FY22 $7.9B
FY23 $7.6B
FY24 $7.4B
FY25 $7.3B
FY26 $7.3B
Net income −16.5%/yr
FY22 $1.3B
FY23 $800M
FY24 $878M
FY25 $798M
FY26 $649M
Character of growth · EPS growth decomposed (2015-2026) −1.1 % p.a.
Revenue per share −2.2 %

of which total revenue −5.4 % · buybacks/dilution +3.3 %

EBIT margin −0.2 %
Tax rate +2.1 %
Residual (interest, one-offs) −0.8 %

Annual growth per factor. These are factors, not summands: multiplied they give the EPS growth rate, added they do not quite. Start and end points are 3-year averages (details on hover).

Watch BBWI: get an alert when its fair value changes →

Share or link this analysis
𝕏 Post WhatsApp LinkedIn Reddit
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "Bath & Body Works Inc. Fair Value". https://www.fairvalue-calculator.com/stock/BBWI

Recent news

External third-party headlines (Yahoo Finance, Reuters and others), not an editorial selection.

Peer Group

Specialty Retail · 219 stocks

How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.

Quality Score 70 · Top 25%
Fair Value upside +115% · Top 25%
Return on assets 14% · Top 25%
Net margin (TTM) 10% · Top 25%
Operating margin (TTM) 11% · Top 25%
Revenue growth −3% · Bottom 25%
Dividend yield (TTM) 4.2% · Above median

Valuation Multiples vs Specialty Retail median · lower = cheaper

P/E (TTM) 5.4× · Cheaper than 75% of peers
P/S (TTM) 0.57× · Pricier than median
P/FCF 4.8× · Pricier than median
EV/EBITDA 5.0× · Cheaper than median
PEG 0.79× · Cheaper than median

Strength profile in five axes (Snowflake)

Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE100 · sector 30
FUTURE0 · sector 25
PAST0 · sector 27
HEALTH100 · sector 96
DIVIDEND84 · sector 56

PAST 0: with negative equity (buybacks among others) return on equity is not meaningfully computable.

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Specialty Retail stocks, each showing price versus our Fair Value estimate (as of Aug 27, 2026).

Stock Price Fair Value vs Fair Value
Alimentation Couche-Tard Inc ATD C$89.93 C$104.32 +16%
Casey's General Stores, Inc CASY $755.47 $398.90 −47%
Williams-Sonoma, Inc WSM $235.09 $162.63 −31%
Ulta Beauty, Inc ULTA $537.10 $475.40 −11%
DICK'S Sporting Goods, Inc DKS $202.66 $181.10 −11%
Best Buy Co BBY $82.44 $108.04 +31%
China Tourism Group 601888 ¥54.97 ¥40.40 −27%
Tractor Supply Company TSCO $34.72 $35.52 +2%
Five Below, Inc FIVE $259.41 $117.29 −55%
Murphy USA Inc MUSA $574.12 $423.35 −26%

Compare Bath & Body Works Inc. with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Explore undervalued stocks

More undervalued Consumer Cyclical stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names ⭐ Top Rated 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

Stock screener Filter by region, size and sector Compare tool Two stocks side by side Extrinsic Value Calculator (Options) Splits an option premium into intrinsic and extrinsic (time) value. Peter Lynch Fair Value Formula & Calculator Apply Peter Lynch's fair value formula in seconds: fair P/E ≈ earnings growth (+ dividend) - free, with formula and example.

Frequently asked questions

Is Bath & Body Works Inc. (BBWI) overvalued or undervalued?
As of Aug 27, 2026, our model estimates a fair value of $40.82 versus a price of $18.97, about +115% upside (undervalued).
What is the fair value of BBWI?
Our model-based fair value for Bath & Body Works Inc. is $40.82 (as of Aug 27, 2026), built from audited fundamentals. The current price: $18.97.
What is the quality score of BBWI?
Bath & Body Works Inc. has a Quality Score of 70/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the revenue of Bath & Body Works Inc. (BBWI)?
Bath & Body Works Inc. reported trailing-twelve-month revenue of about $7.2B (latest available figure, as of Aug 27, 2026).
What is the net profit margin of BBWI?
The net profit margin of Bath & Body Works Inc. is about 10.0%, meaning it keeps roughly 10.0% of revenue as net income. Based on the latest reported figures.
Does Bath & Body Works Inc. pay a dividend?
Bath & Body Works Inc. currently shows a dividend yield of about 4.22% relative to its recent price (as of Aug 27, 2026).
Free · no account needed

Watch Bath & Body Works Inc. in the live analysis

One click puts Bath & Body Works Inc. on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.